B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. 1986

R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul

Supernatants from some mouse helper T cell (TH) lines contain an activity that can enhance IgE production by lipopolysaccharide (LPS)-stimulated B cells by at least two orders of magnitude. During purification, this activity could not be resolved from B cell stimulatory factor-1 (BSF-1). Highly purified BSF-1 from a different source, the T lymphoma cell line EL-4, enhanced IgE production to the same extent as TH supernatants, which suggests that BSF-1 is responsible for this increase in IgE production. Monoclonal antibody to BSF-1 totally inhibits the IgE-enhancing activity of a TH supernatant, lending further support to this conclusion. The effects of BSF-1 on LPS-stimulated B cells are specific for IgE and, as previously reported, IgG1 and IgG3, because the levels of IgM, IgG2a, IgG2b, and IgA in the cultures change relatively little when BSF-1 is added.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
November 1996, International immunology,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
May 1985, Proceedings of the National Academy of Sciences of the United States of America,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
August 1986, The Journal of experimental medicine,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
July 1987, Proceedings of the National Academy of Sciences of the United States of America,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
January 1987, Annual review of immunology,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
July 1987, Journal of immunology (Baltimore, Md. : 1950),
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
December 1986, Proceedings of the National Academy of Sciences of the United States of America,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
August 1987, The Journal of experimental medicine,
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
November 1987, Journal of immunology (Baltimore, Md. : 1950),
R L Coffman, and J Ohara, and M W Bond, and J Carty, and A Zlotnik, and W E Paul
September 1986, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!